Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies

Br J Haematol. 2021 Aug;194(4):788-792. doi: 10.1111/bjh.17551. Epub 2021 May 26.
No abstract available

Keywords: chimaeric antigen receptor-T cells; immunomonitoring; mass cytometry.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / analysis
  • Antigens, CD / immunology
  • Cytophotometry / methods*
  • Flow Cytometry / methods
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Lymphoma, Large B-Cell, Diffuse / immunology
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Receptors, Chimeric Antigen / analysis
  • Receptors, Chimeric Antigen / immunology
  • T-Lymphocytes / immunology

Substances

  • Antigens, CD
  • Receptors, Chimeric Antigen